Recently Published Articles

  1. Baron F, Labopin M, Ruggeri A, Mohty M, Sanz G, Milpied N, Bacigalupo A, Rambaldi A, Bonifazi F, Bosi A, Sierra J, Yakoub-Agha I, Santasusana JM, Gluckman E, Nagler A. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.  J Hematol Oncol. 2015 Oct 6;8(1):107. doi: 10.1186/s13045-015-0207-4.
  2. Michel G, Cunha R, Ruggeri A, O'Brien TA, Bittencourt H, Dalle JH, Locatelli F, Iori AP, Mauad M, Oudin C, Giannotti F, Volt F, Gluckman E, Bader P, Rocha V. on behalf of Eurocord, Cord Blood Committee of Cellular Therapy Immunobiology and Pediatric Disease Working parties of EBMT. Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification. Leukemia. 2015 Sep 15. doi: 10.1038/leu.2015.243.
  3. Pascal L, Tucunduva L, Ruggeri A, Blaise D, Ceballos P, Chevallier P, Cornelissen J, Maillard N, Tabrizi R, Petersen E, Linkesch W, Sengeloev H, Kenzey C, Pagliuca A, Holler E, Einsele H, Gluckman E, Rocha V, Yakoub-Agha I. Impact of ATG-containing reduced-intensity conditioning after single or double-unit allogeneic cord blood transplantation. Blood. 2015 Jul 9. pii: blood-2014-09-599241.
  4. Xavier E, Cornillon J, Ruggeri A, Chevallier P, Cornelissen JJ, Andersen NS, Maillard N, Nguyen S, Blaise D, Deconinck E, Veelken H, Milpied N, Van Gelder M, Peffault de Latour R, Gluckman E, Kröger N, Schetelig J, Rocha V. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, CMWP of the EBMT, and the SFGM-TC. Biol Blood Marrow Transplant. 2015 May 7. pii: S1083-8791(15)00322-5. doi: 10.1016/j.bbmt.2015.04.026. [Epub ahead of print]
  5. Ruggeri A, Labopin M, Sanz S, Piemontese S, Arcese W, Bacigalupo A, Blaise D, Bosi A, Huang H, Karakasis D, Koc Y, Michallet M, Picardi A, Sanz J, Santarone S, Sengeloev H, Sierra J, Vincent L, Volt F, Nagler A, Gluckman E, Ciceri F, Rocha V, and Mohty M. on behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT, ALWP-EBMT study. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia. 17 April 2015; doi: 10.1038/leu.2015.98.
  6. Gluckman E. Umbilical cord blood transfusion in low-income countries. Lancet Haematology. March 2015. Published on line http // dx.doi.org Feb 13.2015 / 10.1016 / S2352-3026 / 00019-8.
  7. Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis J, van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M, Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N. Comparison Of Unrelated Cord Blood (CB) and Peripheral Blood Stem Cell (PB) Transplantation In Adults With Myelodysplastic Syndrome (MDS) After Reduced Intensity Conditioning Regimen (RIC): A Collaborative Study From Eurocord, Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT, and Chronic Malignancies Working Party (CMWP-EBMT). Biol Blood Marrow Transplant. 2014 Dec 18. pii: S1083-8791(14)01384-6. doi: 10.1016/j.bbmt.2014.11.675.
  8. Tucunduva L, Volt F, Cunha R, Locatelli F, Zecca M, Yesilipek A, Caniglia M, Güngör T, Aksoylar S, Fagioli F, Bertrand Y, Addari MC, de la Fuente J, Winiarski J, Biondi A, Sengeloev H, Badell I, Mellgren K, de Heredia CD, Sedlacek P, Vora A, Rocha V, Ruggeri A, Gluckman E; Eurocord and the EBMT Paediatric WP. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. Br J Haematol. 2014 Dec 18. doi: 10.1111/bjh.13267.
  9. Rio B, Chevret S, Vigouroux S, Chevallier P, Fürst S, Sirvent A, Bay JO, Socié G, Ceballos P, Huynh A, Cornillon J, Françoise S, Legrand F, Yakoub-Agha I, Michel G, Maillard N, Margueritte G, Maury S, Uzunov M, Bulabois CE, Michallet M, Clement L, Dauriac C, Bilger K, Gluckman E, Ruggeri A, Buzyn A, Nguyen S, Simon T, Milpied N, Rocha V, SFGM-TC and Eurocord. Decreased Non-relapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial. BBMT 2014 DOI: http://dx.doi.org/10.1016/j.bbmt.2014.11.009
  10. Ruggeri A, Labopin M, Sormani MP, Sanz G, Sanz J, Volt F, Michel G, Locatelli F, Diaz De Heredia C, O’Brien T, Arcese W, Iori AP, Querol S, Kogler S, Lecchi L, Pouthier F,  Garnier F, Navarrete C, Baudoux E,  Fernandes J, Kenzey C, Eapen M, Gluckman E, Rocha V and Saccardi R on behalf of Eurocord, Cord Blood Committee EBMT and  Netcord. Engraftment kinetics and graft failure after single umbilical cord blood transplantation using myeloablative conditioning regimen. Haematologica. 2014 Jun 27. pii: haematol.2014.109280.
  11. Angelucci E, Matthes-Martin S, D Baronciani, Bernaudin F, S Bonanomi, Capellini MD, Dalle JH, Di Bartolomeo P, Diaz de Heredia C, R Dickerhoff, Giardini C, Gluckman E, Hussein AA, Kamani N, Minkov M, Locatelli F, Rocha V, Sedlacek P Smiers F, Thuret I, Yaniv I, Cavazzana M, C Peters on behalf facility oft he Inborn Error and EBMT EBMT Paediatric Working Party. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international panel expert. Haematologica 2014; 99 (5): 811-820.
  12. Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V; Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation. Impact of allele-level HLA matching on outcomes after MAC single unit UCBT for hematologic malignancy. Blood. 2014 Jan 2;123(1):133-40. doi: 10.1182/blood-2013-05-506253. Epub 2013 Oct 18.
  13. Labopin M, Ruggeri A, Gorin NC, Gluckman E, Blaise D, Mannone L, Milpied N, Yakoub-Agha I, Deconinck E, Michallet M, Fegueux N, Socié G, Nguyen S, Cahn JY, de Revel T, Garnier F, Faucher C, Taright N, Kenzey C, Volt F, Bertrand D, Mohty M, Rocha V; Eurocord and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Cost-effectiveness and clinical outcomes of double versus single CBT in adults with Acute Leukemia in France. Haematologica. 2014 Mar;99(3):535-40. doi: 10.3324/haematol.2013.092254. Epub 2013 Oct 18.
  14. Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, Yakoub-Agha I, Ribera JM, Mannone L, Sierra J, Mohty M, Solano C, Nabhan S, Arcese W, Gluckman E, Labopin M, Rocha V; Eurocord and Acute Leukemia Working Party of European Blood and Marrow Transplant Group. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. Leukemia 2013 Sep 5. doi: 10.1038/leu.2013.259.
  15. Cunha R, Loiseau P, Ruggeri A, Sanz G, Michel G, Iori AP, Socié G, Arcese W, Picardi A, Dias de Heredia C, Rio B, Locatelli F, O'Brien TA, Yakoub-Agha I, Angel Diaz M, Milpied N, Bittencourt H, Pedro Souza M, Aljurf M, Charron D, Boudjedir K, Labopin M, Gluckman E, Rocha V. Impact of HLA mismatch direction on outcomes after UCBT for hematological malignant disorders: a retrospective Eurocord-EBMT analysis, Bone Marrow Transplantation 2013 Aug 19. doi: 10.1038/bmt.2013.120.
  16. Tucunduva L, Ruggeri A, Sanz G, Furst S, Socié G, Michallet M, Arcese W, Milpied N, Yakoub-Agha I, Linkesch w, Cornelissen J, Mannone L, Iori, Ribera J-M, Sanz J, Montesinos P, Purtill D, Labopin M, Gluckman E, Mohty M and Rocha V. Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 2014 Jul;49, 887-894 | doi:10.1038/bmt.2014.72
  17. Rodrigues CA, Rocha V, Dreger P, Brunstein C, Sengeloev H, Finke J, Mohty M, Rio B, Petersen E, Guilhot F, Niederwieser D, Cornelissen JJ, Jindra P, Nagler A, Fegueux N, Schoemans H, Robinson S, Ruggeri A, Gluckman E, Canals C, Sureda A; Eurocord-Netcord and the Lymphoma Working Party; Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with UCB and unrelated donor peripheral blood,Haematologica 2014 Feb;99(2):370-7. doi: 10.3324/haematol.2013.088997.
  18. Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML, Zecca M, Kurtzberg J, Bonfim C, Vora A, Díaz de Heredia C, Teague L, Stein J, O'Brien TA, Bittencourt H, Madureira A, Strahm B, Peters C, Niemeyer C, Gluckman E, Rocha V. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood 2013 Sep 19;122(12):2135-41. doi: 10.1182/blood-2013-03-491589.
  19. Locatelli F, N Kabbara, Ruggeri A, Ghavamzadeh A, Roberts I, CK Li, Bernaudin F, C Vermylen, Slab JH, Stein J, R Wynn, Cordonnier C, Pinto F, Angelucci E, G Socié, Gluckman E, MC Walters Rocha V. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013 Aug 8;122(6):1072-8. doi: 10.1182/blood-2013-03-489112.
  20. Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O'Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V; Eurocord; Inborn Errors Working Party of European Blood and Marrow Transplant group; Duke University Blood and Marrow Transplantation Program; Centre for International Blood and Marrow Research. Outcomes of Transplantation using various Hematopoietic cell sources in Children with Hurler's-Syndrome after MAC. Blood 2013 May 9;121(19):3981-7. doi: 10.1182/blood-2012-09-455238.
  21. Rocha V, Labopin M, Ruggeri A, Podestà M, Gallamini A, Bonifazi F, Sanchez-Guijo FM, Rovira M, Socie G, Baltadakis I, Michallet M, Deconinck E, Bacigalupo A, Mohty M, Gluckman E, Frassoni F. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies. Transplantation 2013 May 27;95(10):1284-91.
  22. Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Ahmed Hussein A, Carlson K, Cornillon J, Diez-Martin J.L, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek M.A, Herr A.L, Gluckman E, Farge D, and Rocha V. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the AIDWP of EBMT. Blood 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965.
  23. Ruggeri A, Rocha V, Masson E, Labopin M, Cunha R, Absi L, Boudifa A, Coeffic B, Devys A, De Matteis M, Dubois V, Hanau D, Hau F, Jollet I, Masson D, Pedron B, Perrier P, Picard C, Ramouneau-Pigot A, Volt F, Charron D, Gluckman E, Loiseau P. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis. Haematologica 2013 Jul;98(7):1154-60. doi: 10.3324/haematol.2012.077685.
  24. Dumas PY, Ruggeri A, Robin M, Crotta A, Abraham J, Forcade E, Bay JO, Michallet M, Bertrand Y, Socié G, Ionescu I, Gluckman E, Milpied N, Rocha V. Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and SFGM-TC collaborative study. BMT 2013 Feb;48(2):253-6. doi:10.1038/bmt.2012.11
  25. Gluckman E. Allogeneic transplantation strategies haploidentical transplantation Including in sickle cell disease. Am Soc Hematol Hematol Educa Program. 2013; 2013.370-6.doi 10.1182 / asheducation-2013.1.370.

Words of president
- Eliane Gluckman -

Major improvement has been observed in the field of hematopoietic stem cell...
Read more


Eurocord Monaco

MONACORD is a clinical research organisation, which has established at the Centre Scientifique de Monaco

Read more